FDA to conduct unannounced inspections on foreign facilities supplying U.S. products.

The FDA plans to expand unannounced inspections at foreign facilities producing food and medical products for the U.S., ensuring a consistent level of oversight with domestic companies. Previously, foreign firms were often given advance notice, but unannounced inspections found more serious issues. This move aims to enhance product safety and quality, targeting potential record falsification and violations.